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Introduction
Morphogenesis transforms the C. elegans embryo from a
roughly spherical ball into a long, thin worm. In contrast to
most other animal systems, C. elegans morphogenesis occurs
in the absence of widespread cell growth, proliferation or
movements (reviewed by Chin-Sang and Chisholm, 2000;
Simske and Hardin, 2001). Embryonic elongation occurs when
actin filaments within a subset of epidermal cells (the lateral
epidermal or ‘seam’ cells) shorten, causing the cells, and the
embryo, to lengthen. Actin is initially disorganized within the
lateral epidermal cells; however, at the onset of elongation,
actin organizes into filaments that shorten as elongation
proceeds (Priess and Hirsh, 1986).
let-502/Rho-binding kinase (ROK) and mel-11/myosin
phosphatase targeting subunit (MYPT or myosin-binding
subunit MBS) regulate the cell shape changes within the lateral
epidermal cells to drive elongation. Based on genetic data
coupled with the known functions of their vertebrate homologs
in the regulation of smooth muscle contraction and focal
adhesions formation (Kaibuchi et al., 1999; Pfitzer, 2001;
Piekny et al., 2000; Shelton et al., 1999; Somlyo and Somlyo,
2000; Wissmann et al., 1997), let-502 and mel-11 probably
regulate elongation by altering the activity of myosin.
Contraction is triggered by phosphorylation of regulatory
myosin light chain (rMLC, mlc-4 in C. elegans) by myosin
light chain kinase or integrin-linked kinase (Pfitzer, 2001;
Somlyo and Somlyo, 2000). Myosin phosphatase in turn
removes the activating phosphate from rMLC, preventing
contraction. Activation of ROK by the small GTPase Rho
results in an inhibitory phosphorylation of the targeting subunit
MYPT of myosin phosphatase, releasing the block to
contraction. let-502/ROK and mlc-4/rMLC mutants fail to
elongate, while mel-11/MYPT mutants hypercontract. 
The Drosophila homologs Drok/ROK and MYPT similarly
regulate morphogenetic processes. Nonmuscle MHC zipper
and rMLC spaghetti-squash, Drok and Mypt/Dmbs are
required for dorsal closure (Mizuno et al., 2002; Tan et al.,
2003; Winter et al., 2001; Young et al., 1993). These
molecules also are involved in other developmental processes
such as epidermal planar polarization (Winter et al., 2001).
Therefore, nonmuscle myosin, ROK and MYPT probably
comprise a conserved ‘cassette’ that is used for many
Rho-binding kinase and the myosin phosphatase targeting
subunit regulate nonmuscle contractile events in higher
eukaryotes. Genetic evidence indicates that the C. elegans
homologs regulate embryonic morphogenesis by
controlling the actin-mediated epidermal cell shape
changes that transform the spherical embryo into a
long, thin worm. LET-502/Rho-binding kinase triggers
elongation while MEL-11/myosin phosphatase targeting
subunit inhibits this contractile event. We describe
mutations in the nonmuscle myosin heavy chain gene
nmy-1 that were isolated as suppressors of the mel-11
hypercontraction phenotype. However, a nmy-1 null allele
displays elongation defects less severe than mutations in let-
502 or in the single nonmuscle myosin light chain gene mlc-
4. This results because nmy-1 is partially redundant with
another nonmuscle myosin heavy chain, nmy-2, which was
previously known only for its role in anterior/posterior
polarity and cytokinesis in the early embryo. At the onset
of elongation, NMY-1 forms filamentous-like structures
similar to actin, and LET-502 is interspersed with these
structures, where it may trigger contraction. MEL-11,
which inhibits elongation, is initially cytoplasmic. In
response to LET-502 activity, MEL-11 becomes sequestered
away from the contractile apparatus, to the plasma
membrane, when elongation commences. Upon completion
of morphogenesis, MEL-11 again appears in the cytoplasm
where it may halt actin/myosin contraction.
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developmentally-specific contractile processes during animal
development. 
To identify new components of the C. elegans elongation
pathway, we screened for suppressors of the mel-11
hypercontraction phenotype (Piekny et al., 2000). Here, we
describe nmy-1, which encodes a nonmuscle myosin heavy
chain (MHC). Genetic evidence is consistent with nmy-1 acting
as a partner for MLC-4/rMLC, the downstream target for
LET-502/ROK and MEL-11/MYPT. However, the nmy-1 null
mutant phenotype is less severe than mlc-4 or let-502,
suggesting that nmy-1 functions redundantly. Indeed, we found
that nmy-2, previously known only for its requirement in the
early embryo (Cuenca et al., 2003; Guo and Kemphues, 1996)
acts in concert with nmy-1. In addition, NMY-1 antisera reveal
that this protein forms filamentous-like structures in the lateral
epidermal cells during elongation.
The expression pattern of LET-502 and MEL-11, determined
by GFP transcriptional reporters, is consistent with their
functioning as regulators of elongation (Wissmann et al.,
1999). LET-502, the trigger for contraction, is expressed in the
same lateral epidermal cells as MLC-4 that drive elongation
(Shelton et al., 1999; Wissmann et al., 1999). MEL-11, the
negative regulator of contraction, is also expressed within these
cells; however, at lower levels than in the neighboring dorsal
and ventral epidermal cells (Wissmann et al., 1999). A caveat
is that these reporters revealed only zygotic transcription,
although either maternal or zygotic activity of the two genes
suffices for viability. Therefore we do not know precisely in
which cells the genes act nor the mechanism by which LET-
502 and MEL-11 regulate epidermal cell shape changes. For
example, they could regulate myosin contraction and/or tether
actin cables to the membrane during morphogenesis. Using
antisera against LET-502 and MEL-11, we show that both
proteins are expressed in the lateral epidermal cells during
elongation. Although LET-502 localizes near myosin
throughout elongation, MEL-11 becomes sequestered away
from the contractile apparatus in response to LET-502 activity.




C. elegans were maintained under standard conditions (Brenner,
1974). Strains were constructed using standard procedures, and cis-
linked morphological markers were often used to follow the mutations
used through crosses. Homozygous lethal or sterile mutations were
maintained as heterozygous stocks balanced either with appropriate
crossover suppressors or normal chromosomes with flanking
morphological markers. To determine hatching rates of different
genetic combinations, as many L4 hermaphrodites as needed were
brooded at the appropriate temperatures until they ceased laying
fertilized embryos; a minimum of 300 progeny were scored unless
otherwise noted (Mains et al., 1990).
Nomenclature follows that of Horvitz et al. (Horvitz et al., 1979).
Genes, alleles and balancer chromosomes listed are below;
descriptions can be found in Edgley et al. (Edgley et al., 1995),
Hodgkin (Hodgkin, 1997) and in Wormbase (www.wormbase.org).
Linkage Group I: let-502(ca201, sb106ts and sb108), dpy-5(e61),
rde-2(ne221). Linkage Group II: mel-11(it26ts and sb55), unc-
4(e120), sqt-1(sc13). Linkage Group III: mlc-4(or253). Linkage
Group V: sma-1(e30). Linkage Group X: unc-115(e2225), dpy-
8(e130), unc-78(e1217), spc-1(ra409), nmy-1(sb92, sb113 and
sb115), unc-2(e55). Balancer chromosomes: the crossover suppressor
mnC1 II was used to balance mel-11.
Single nucleotide polymorphism mapping
Single nucleotide polymorphism mapping was performed as
described by Wicks et al. (Wicks et al., 2001). The Dumpy (Dpy) and
Lumpy phenotype of sb113 was mapped to the left arm of LGX by
crossing with the Hawaiian strain CB4856 and using primers
indicated in Wicks et al. (Wicks et al., 2001). Another mutant, sb115,
was mapped to the left arm of LGX between dpy-8 and unc-115 via
classical genetics. sb92 has no phenotype on its own but was mapped
between unc-2 and unc-78 based on suppression of mel-11. sb115
dpy-8 was crossed to CB4856, and Lumpy non-Dpy and Dpy non-
Lumpy recombinants were selected, mapping sb115 between
polymorphisms Y41G9A and F52E4 (data submitted to Wormbase).
Cosmid F52B10 is within this region and contains nmy-1. Two
independent PCR products spanning nmy-1 in sb92, sb113 and sb115,
were sequenced (University of Calgary Core DNA Sequencing
Laboratory) (Piekny et al., 2000) and were found to contain mutations
(see Results). 
Microscopy and immunofluorescence
Embryos were dissected from gravid hermaphrodites that had been
incubated without food for 1 hour. This induces animals to hold their
eggs, enriching for mid-stage embryos. Embryos were mounted in M9
solution (Horvitz and Sulston, 1980) or larva and adults were placed
in anaesthetizing solution (0.1% tricaine, 0.01% tetramisole) on 3%
agarose pads. Specimens were examined by Nomarski optics on a
Zeiss Axioplan 2 microscope, and images were photographed using
the Hamamatsu Orca ER digital camera and collected using
Axiovision 3.0 for Windows NT.
For indirect immunofluorescence, mid-staged embryos were placed
on polylysine-coated slides in M9. A cover slip was placed on each
slide, and the embryos were frozen on dry ice for at least 30 minutes.
The cover slips were cracked off, and slides were placed in –20°C
methanol for 10 minutes, followed by 20 minutes in –20°C acetone,
then rehydrated with 90% ethanol for 10 minutes at –20°C, 60%
ethanol for 10 minutes at –20°C, then 30% ethanol for 10 minutes at
room temperature. For actin and some NMY-1 staining, freeze-
cracked slides were placed in a 3.7% formaldehyde solution (w/v) in
1· phosphate-buffered saline (PBS) at room temperature for 10
minutes and then placed in 1 · PBS with 0.1% Tween-20 (PBT). For
all methods, the slides were placed directly into 1 · PBT for a
minimum of 1 hour, then incubated with appropriate dilutions of
antisera in PBT with 20% normal goat or donkey serum (Jackson
Immunoresearch Laboratories). F-actin was stained with phalloidin-
Alexa 488 (Molecular Probes; 10 m l/slide was placed into a tube and
the methanol was evaporated overnight, then 1 · PBT was added with
20% normal goat serum and other antisera if needed). Rabbit anti-
NMY-2 polyclonal antibodies (Guo and Kemphues, 1996) were used
at a 1:50 dilution, rabbit anti-MEL-11 polyclonal antibodies at 1:50
(Piekny et al., 2002), rat anti-LET-502 polyclonal antibodies at 1:50
(Piekny et al., 2002), rat anti-NMY-1 polyclonal antibodies (see
below) at 1:200 and rabbit anti-NMY-1 polyclonal antibodies (see
below) at 1:1000. All slides were incubated with primary antibodies
for 1 hour to overnight at room temperature and washed three times
with PBT. Anti-rat IgG conjugated to indocarbocyanine (Cy-3;
Jackson Immunoresearch Laboratories) and anti-rabbit IgG
conjugated to Alexa 488 (Molecular Probes) were used at a 1:100
dilution in PBT, and slides were incubated at room temperature for 1
hour. Slides were washed three times with PBT and soaked in 1 m g/ml
DAPI (Roche) for 1 minute at room temperature, washed with PBT,
then mounted with a drop of Slowfade Light Antifade solution
(Molecular Probes). Images were collected using Axiovision 3.0 for
Windows NT as stacks of 20 · 1 m m from a Zeiss Axioplan 2
microscope using a 63 · oil objective with the Hamamatsu Orca ER
digital camera. Stacks were digitally deconvolved using the
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constrained iterative algorithm of Axiovision 3.0 for Windows NT.
Superficial stacks corresponding to epidermal cells or internal stacks
corresponding to the pharyngeal/intestinal region were analyzed with
Adobe Photoshop version 4.0 for Windows.
RNA-mediated interference (RNAi)
Double-stranded RNA (dsRNA) was generated for nmy-1 and nmy-2.
The primers for nmy-1 were made to the C-terminal region of the
coding sequence (sequence identity <80% with nmy-2). The primers
were: forward primer (including the T3 promoter) 5¢ AATTAAC-
CCTCACTAAAGGGGCAACATCAACTGACGAG3 ¢ and reverse
primer (including the T7 promoter) 5 ¢ TAATACGACTCACTATAG-
GGAGCATCGAGAAGATCGTC3 ¢ . Primers for nmy-2 similarly were
made to the C-terminal portion of the coding sequence showing lower
sequence homology to nmy-1. The primers were: forward primer
(including the T3 promoter) 5 ¢ AATTAACCCTCACTAAAGGGGA-
CGAGACTCGATGCTGA3 ¢ and reverse primer (including the T7
promoter) 5¢ TAATACGACTCACTATAGGGATCTCTGGAGAGTG-
TCTC3 ¢ . dsRNA was made from the PCR products and used for
soaking worms as described in Piekny and Mains (Piekny and Mains,
2002). dsRNA to nmy-1, nmy-2 and both together were injected as
described by Fire et al. (Fire et al., 1998) with concentrations varying
from 10-6 m g/m l to 1 m g/m l for each gene. Some nmy-2 RNAi
experiments were performed using bacteria expressing dsRNA from
the feeding library described by Fraser et al. (Fraser et al., 2000). L4
or young adult were cultured for 1-2 days until first broods were
obtained and were passaged to plates seeded with normal E. coli for
subsequent broods.
NMY-1 antisera
Rat polyclonal antibodies were generated using a GST-NMY-1 fusion
encoding C-terminal region amino acids 941-1133, which was
amplified using the following primers: forward (containing the BamHI
restriction site) 5¢ TACAGGATCCGAGAAACCGTCCGTGATCTC3 ¢
and reverse (containing the EcoRI restriction site) 5¢ CGAGGAATTC-
CCTTGTCATTTCTGCCTTAT3¢ and cloned directionally into the
pGEX-3X vector (Pharmacia). Rat injections were performed as
described previously (Piekny and Mains, 2002). Rabbit polyclonal
antibodies were raised against a GST-NMY-1 fusion by the Peptide
Group from Macromolecular Resources. All antisera were purified by
subtracting against a glutathione-sepharose 4B column (Pharmacia).
Western blot analysis showed that all of the antisera recognized a
predominant band above 200 kDa (expected ~230 kDa) with gravid
adult hermaphrodite extracts obtained by 1 · PBS and with extracts
further solubilized with 1 M NaCl, implying that pools of NMY-1 are
both cytoplasmic and associated with the cytoskeleton (data not
shown). The band was blocked by adding excess GST-NMY-1 to the
antisera (data not shown) and immunostaining was not detectable in
nmy-1(sb115) (data not shown but see results), which truncates the
protein before the region used for immunization.
Results
Identification of a new component of the let-502/mel-
11 pathway
Previously we performed a screen for suppressors of mel-11 to
identify new genes in the let-502/mel-11 pathway (Piekny
et al., 2000). sb92, sb113 and sb115 are semi-dominant
suppressors (Table 1) that failed to complement for Dpy,
Lumpy and Roller (Rol) phenotypes (genetic properties will be
described below). sb115 was mapped near cosmid F52B10
(Materials and methods), which contains a single gene, nmy-
1. As diagrammed in Fig. 1, nmy-1 is predicted to encode a
1963 amino acid nonmuscle MHC, with an N-terminal SH3-
like domain, a myosin motor head followed by a myosin
coiled-coil tail. sb92 included a Glu(285)Val mutation, sb113
Gly(647)Glu and sb115 Gln(480)stop. All are in highly
conserved residues within the head domain (Fig. 1). The
myosin head and tail are highly conserved between NMY-1 and
the Drosophila nonmuscle MHC, Zipper, human MHCB and
another C. elegans MHC, NMY-2 (Fig. 1; see Fig. S1 at
http://dev.biologists.org/supplemental/) (Guo and Kemphues,
1996; Mansfield et al., 1996; Philips et al., 1995; Young et al.,
1993). Overall, NMY-1 shares highest amino acid identity
(48%) with Drosophila Zipper and human MHCB. NMY-1
shares 45% identity with C. elegans NMY-2, suggesting that
they are paralogs.
RT-PCR revealed one predominant SL1-spliced transcript of
~6000 bp, similar to the predicted length of 6383 nucleotides
(data not shown). Sequencing confirmed the predicted
intron/exon structure of nmy-1 found at Wormbase
(www.wormbase.org). In addition, microarray data predicts
that nmy-1 is most highly expressed during embryogenesis
(Hill et al., 2000).
Table 1. Genetic interactions between nmy-1 and genes in the let-502/mel-11 elongation pathway
20°C 25°C
Hatching L1 arrest Hatching L1 arrest
Genotype (%) (% of hatched)* (%) (% of hatched)*
mel-11(it26) 4 –† 0 –
mel-11(it26); nmy-1(RNAi) 71 Range of arrest – –
mel-11(it26); nmy-1(sb92)/+ 23 0 – –
mel-11(it26); nmy-1(sb92) 68 0 – –
mel-11(it26); nmy-1(sb113)/+ 48 5 23 44
mel-11(it26); nmy-1(sb113) 75 62 64 84‡
mel-11(it26); nmy-1(sb115)/+ 35 56 27 74
let-502(sb108) 100 0 92 0
let-502(sb108); nmy-1(sb115) – – 88 82
mel-11(it26); spc-1(ra409)/+ 7 100 – –
mel-11(sb55) – – 6 0
sma-1(e30) – – 95 7
mel-11(sb55); sma-1(e30) – – 94 86
mel-11(it26); sma-1(e30) 68 92 – –
*The L1 arrest phenotype was like mlc-4 shown in Fig. 2, and differed from the slow-growing L1-L3 Lumpy Dpy larva observed in nmy-1 homozygotes alone.
†Not determined.
‡All non-arrested animals were Lumpy Dpy.
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A previous large-scale RNAi survey reported sterility,
lethality and Dpy and uncoordinated (Unc) phenotypes for
nmy-1 (Kamath et al., 2003). However, short regions of high
DNA sequence identity to nmy-2 in the myosin head domain
could result in RNAi crossreactivity. We performed nmy-1
gene-specific RNAi (Materials and methods) and observed
little embryonic lethality but did see Dpy Lumpy phenotypes
identical to those of our nmy-1 alleles sb113 and sb115. Like
our nmy-1 alleles, injection of nmy-1 dsRNA suppressed mel-
11 lethality (Table 1).
nmy-1 alleles behave as semi-dominant suppressors of mel-
11 with stronger suppression when homozygous (Table 1).
Although suppressed mel-11; nmy-1 embryos hatch, a large
proportion of the early larva with sb113 and sb115 arrested
with an elongation phenotype similar to let-502 and mlc-4. For
example, 84% of mel-11(it26); nmy-1(sb113) larva that
hatched at 25°C displayed L1 arrest without elongation, in
comparison to nmy-1(sb113) alone, which displayed 1-4% L1-
L3 larva arrest/slow growth (Table 2). All escapers showed the
sb113 Dpy, Lumpy phenotype, indicating that mel-11 did not
reciprocally suppress the nmy-1 morphological defects. All
mel-11(it26); nmy-1(sb115) larva displayed L1 arrest
compared with 30% for sb115 alone (data not shown). 
Characterization of nmy-1
Our alleles of nmy-1 are the first reported for this gene. sb92
has no obvious phenotypes on its own, while sb113 and sb115
are Dpy Lumpy Rol with some embryonic lethality (Table 2).
All sb113 and sb115 L1 larva display bulging at the anterior
(Fig. 2A,D), which usually disappears as the animals grew.
sb113 had a small percentage (1-4%) of slow growth or larval
arrested between L1-L3 while the value was 30% for sb115.
sb113 and sb115 adults are Dpy, Lumpy and sometimes Rol,
consistent with non-lethal elongation defects, and adult
hermaphrodites have low brood sizes (Table 2). Larva and
adults have small pharynxes (Fig. 2G,H) and possible intestinal
defects as bacteria accumulate in their guts. In addition, the
adults show varying degrees of Unc, although whether this is
a secondary consequence of the elongation defects remains to
be determined. Gonad arms sometimes fail to migrate correctly
(e.g. fail to turn in the DV axis), but this is probably a
secondary consequence of other elongation defects as the distal
tip cell migration is normal in L4 larva (data not shown).
All of the nmy-1 alleles behave as loss-of-function alleles.
The phenotypes of sb113 and sb115 are unchanged when
heterozygous with each other or a chromosomal deficiency of
the region (data not shown). sb92 is more severe in trans to
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Fig. 1. Schematic representation of the
predicted NMY-1 structure. The N
terminus contains an SH3-like domain
and a myosin motor domain, which
contains the MLC binding sites (one for
the regulatory MLC and one for the
essential MLC). The C terminus
includes a coiled-coil myosin tail
domain, probably involved in MHC
dimerization. nmy-1 mutations are
indicated. The overall amino acid
identities between NMY-1 and
Drosophila Zipper, human MHCB and
C. elegans NMY-2 are shown as well as
the identities between the SH3, myosin
motor and myosin tail domains.
Table 2. The phenotypes, hatching rates and brood sizes of nmy-1 alleles
15°C 20°C 25°C
Hatching Average Hatching Average Hatching Average 
Parental genotype Progeny phenotypes (%) brood (%) brood (%) brood
sb113 Lumpy, Dpy, Rol* 91† 20 84† 32 89† 22
sb113 · +/+ male Wild type 100 150 99 190 99 127
sb115 Lumpy, Dpy, Rol* 76‡ 15§ 80‡ 12 74‡ 13
sb115 · +/+ male Wild type 99 187 99 168 99 156
sb92 Wild type 99 213 96 256 93 230
nmy-1(RNAi)¶ Lumpy, Dpy, Rol* –** – 95 – – –
*All L1 larva showed severe Lumpy Dpy phenotypes that often disappeared by adulthood. The adults showed a range of phenotypes including mild Lumpy
Dpy, and Rol. Some were also Unc.
†Approximately 1-4% grew slowly or arrested between L1-L3.
‡Approximately 30% grew slowly or arrested between L1-L3.
§n=115. n>300 for all other table entries.




either allele or the deficiency than when homozygous,
indicating that it represents a partial loss-of-function.
sb115 is likely a null allele based on its phenotypes
and molecular lesion (a truncation in the N-terminal
myosin head domain). sb113 and sb115 phenotypes
were rescued by crossing mutant hermaphrodites to
wild-type males, indicating zygotic activity of the
genes (Table 2). sb115/sb92 and sb113/sb92
hermaphrodites show more severe phenotypes when
the stronger alleles are maternally inherited, indicating
some maternal activity, even though the NMY-1
protein is not detected in early embryos (data not
shown).
NMY-1 is redundant with NMY-2
Although NMY-1 is predicted to partner with MLC-4,
nmy-1(null) is viable while the mlc-4(null) is lethal
(Shelton et al., 1999); all mlc-4 mutant larva arrest at
L1 with failed elongation (Fig. 2B). This result implies
that nmy-1 is not the only myosin target of the let-
502/mel-11 pathway. NMY-2 is a nonmuscle MHC
with high levels of sequence similarity to NMY-1 (Fig.
1) and has been characterized for its role in
anterior/posterior polarity and cytokinesis using RNAi
(Cuenca et al., 2003; Guo and Kemphues, 1996).
Because RNAi results in early, lethal defects, the role
of nmy-2 in elongation has not been explored.
To determine if nmy-2 could potentially function
redundantly with nmy-1, we stained wild-type
embryos with NMY-2 antisera to determine if the
protein persists through elongation. NMY-2
expression levels decreased with time, but it is
presented at low levels in all cells, including epidermal
cells, until after the onset of elongation, and this
pattern was not altered in nmy-1 mutant (Fig. 3A-I).
To establish redundancy between nmy-1 and nmy-2,
we performed nmy-2(RNAi) in wild-type and nmy-1
mutant worms. To avoid the block of nmy-2(RNAi) at
the one-cell stage, we used feeding as the means of
dsRNA delivery, which gradually eliminates gene
function over several days, permitting us to examine
nmy-1 interactions. The broods on the first day after
reaching adulthood displayed 52% embryonic
viability (Table 3), indicating that nmy-2 was
incompletely eliminated. However, L1 arrest
phenotypes were never observed. nmy-2(RNAi); nmy-
1(sb113 or sb115) displayed the same level of
embryonic lethality as nmy-2(RNAi) alone, but half of
the hatching embryos showed L1 arrest similar to mlc-
4 (Fig. 2B,E,F; Table 3). Although we normally see
low levels of L1-L3 slow growth/arrest in both nmy-
1(sb113) and nmy-1(sb115) alone, the L1 arrest
phenotype seen in the double mutants was much
stronger and distinctly like that seen in mlc-4 (and let-
502). The enhancement of nmy-1 elongation defects by nmy-2
suggests redundancy. Finally, rde-2(ne221), which shows
partial resistance to RNAi (Tabara et al., 1999) and thus may
bypass the early block, produced 13% embryos with failed
elongation when grown on nmy-2(RNAi) bacteria compared
with none when fed normal bacteria (Table 3).
As nmy-1 and let-502 both suppress mel-11, we expected to
see enhancement between nmy-1 and let-502 (Piekny et al.,
2000). let-502(sb108), a weak loss-of-function allele, shows no
larval arrest, while approximately one-third of nmy-1(sb115)
do so. However, let-502(sb108); nmy-1(sb115) showed 82%
L1 arrested with failed elongation (Table 1). Similar results
were seen with other nmy-1 and let-502 allelic combinations
(data not shown). Therefore, loss of nmy-1 (which results in a
Fig. 2. Nomarski images of mutant L1 larva. (A) Wild type, (B) mlc-4, (C) let-
502(ca201), (D) nmy-1(sb115) and (E,F) nmy-1(sb115); nmy-2(RNAi). (G,H)
The adult pharynx of wild-type and nmy-1(sb115) hermaphrodite are indicated
by brackets. Scale bars: 10 m m.
Fig. 3. NMY-1 and NMY-2 expression in nmy-1(sb115) mutant embryos. nmy-
1(sb115) embryos were stained for DAPI (left column), NMY-2 (middle
column) and NMY-1 (right column). NMY-2 was expressed prior (B), during
(E) and after (H) elongation, although levels decreased. Anti-NMY-1 antisera
failed to stain these embryos (C,F,I), with the exception of a low level of
crossreactivity in muscle (I). Scale bar: 10 m m. 
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partial loss of total NMY protein) synergizes with a partial loss
of let-502, consistent with both acting in the same pathway.
NMY-1, LET-502 and MEL-11 localization during
elongation
Our genetic results predict NMY-1 expression in the lateral
epidermis during elongation. NMY-1 antisera revealed that it
is indeed highly expressed in these cells at the onset of
elongation (Fig. 4B), similar to that observed by Shelton et al.
(Shelton et al., 1999) for MLC-4. NMY-1 was also present at
the adherens junctions (AJs) of the developing pharynx (data
not shown). As elongation proceeded, NMY-1 became more
punctate (Fig. 4D) and organized into filamentous-like
structures (Fig. 4F). Embryos of similar stages stained for actin
showed a similar pattern, albeit filamentous structures become
apparent earlier (Fig. 4A,C,E; embryos were not co-stained
because NMY-1 and actin require incompatible fixation
methods). Both actin and myosin organize into filaments that
run perpendicular to the axis of elongation and are thus
potentially arrayed to draw the lateral epidermal cells together
in the dorsal/ventral axis, causing embryonic elongation.
The immunolocalization patterns of MEL-11 and LET-502
during morphogenesis is consistent with the hypothesis that
they regulate the activity of myosin. Prior to elongation, LET-
502 and MEL-11 showed extensive colocalization in the
cytoplasm with punctate staining at epidermal cell boundaries
(Fig. 5A-C). As elongation proceeded, MEL-11 became
enriched and was restricted to cell boundaries while LET-502
remained primarily cytoplasmic (Fig. 5D-F). When elongation
was completed, MEL-11 again increased in the cytoplasm, with
decreased, punctate localization at cell boundaries, similar to
the pre-elongation pattern (Fig. 5J-L). Both proteins were also
expressed at the AJs of the developing pharynx and intestine
(Fig. 5G-I) and in the germline precursor cells (data not shown). 
These data suggest that LET-502, but not MEL-11, is in a
region where it can influence contractions of actin/myosin
filaments during elongation. Indeed, as elongation proceeded,
punctate anti-LET-502 staining interspersed with the NMY-1
filaments (Fig. 6A-D). By contrast, MEL-11 was membrane
bound, away from NMY-1 (Fig. 6E-H). The vertebrate MEL-
11 homolog, MYPT, moves to the plasma membrane after
phosphorylation by ROK, where it remains sequestered from
actin/myosin to allow contraction (Shin et al., 2002). To
determine if MEL-11 was similarly influenced by let-502
activity, we examined MEL-11 localization in let-502 mutants.
Indeed, using the strong let-502(ca201) allele, MEL-11
remained mostly cytoplasmic with punctate cell membrane
localization (Fig. 7A,B), similar to its distribution wild-type
embryos prior to elongation (Fig. 5B). Because let-502(ca201)
mutant embryos arrest at the onset of elongation, disrupted
staining could arise as a secondary consequence of
developmental arrest. Therefore, we examined MEL-11
localization in a partial loss-of-function let-502(sb106) mutant,
which does elongate. Although less dramatic compared with
the strong allele let-502(ca201), we again found higher levels
of cytoplasmic MEL-11 in the in let-502(sb106) embryos
compared with wild type (Fig. 7C,D). This suggests that the
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Table 3. Redundancy between nmy-1 and nmy-2 during elongation
Day one Day two
Hatching L1 arrest† Hatching L1 arrest† 
Genotype* (%) (% of hatched) (%) (% of hatched)
nmy-2(RNAi) 52 0 0‡ –§
nmy-2(RNAi); nmy-1(sb113) 51 56 6 100
nmy-2(RNAi); nmy-1(sb115) 47¶ 53 Ste –
rde-2f – – 100 0
nmy-2(RNAi); rde-2** – – 85 13
*RNAi was performed by feeding.
†The L1 arrest phenotype observed was a severe, Mlc-4-like arrest shown in Fig. 2B. This phenotype differed from the slow-growing L1-L3 Lumpy Dpy larva
noted in Table 2.
‡n=117, all others values in the table are more than 190.
§Not determined.
¶n=109.
**Hermaphrodites were fed nmy-2(RNAi) for 1 day and were transferred to plates with normal bacteria for the day two brood.
Fig. 4. NMY-1 and actin localization during elongation. Actin
(A,C,E) and NMY-1 (B,D,F) localization are shown in deconvolved
images of superficial sections of comparably-staged 1.5 to 3.0-fold
wild-type embryos using immunofluorescence. Owing to
incompatibilities with fixation methods for actin and NMY-1, we
could not co-stain embryos. Scale bar: 10 m m.
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disappearance of the cytoplasmic MEL-11 pool, which occurs
at the onset of elongation and which could potentially inhibit
myosin activity, is at least partly dependent on let-502(+)
activity. This is consistent with the antagonistic genetic
interactions of let-502 and mel-11.
Although the above evidence supports the model that LET-
502 and MEL-11 regulate myosin activity to drive elongation,
another (not mutually exclusive) model proposes that LET-502
and MEL-11 regulate anchoring of actin cables to the
membranes of the lateral epidermal cells. Elongation-defective
Fig. 5. LET-502 and MEL-11
immunolocalization in wild-type
embryos. Embryos in the first
column are stained with anti-LET-
502, middle column with anti-MEL-
11 and merged images are presented
in the right column (LET-502 red,
MEL-11 green). (A-C) 1.0- to 1.5-
fold embryo showing extensive
colocalization of LET-502 and
MEL-11 in all epidermal cells.
(D-F) Twofold embryo is shown at a
plane corresponding to the
epidermal cells where MEL-11 is
restricted to epidermal cell
boundaries while LET-502 remains
cytoplasmic. (G-I) Twofold embryo
at a plane corresponding to pharynx
and intestine, where LET-502 and
MEL-11 colocalized at adherens
junctions. (J-L) Threefold embryo
showed cytoplasmic LET-502, while
MEL-11 showed punctate staining
at the cell boundaries, with a limited
amount reappearing in the
cytoplasm (compare E and K). All
images were deconvolved. Scale
bars: 10 m m.






Merged image is shown in
C (LET-502 red, NMY-1
green). A magnified view
of C is shown in D. MEL-
11 was restricted to
epidermal cell boundaries
(F) away from NMY-1
(E), with a merged image
shown in G (NMY-1 red,
MEL-11 green). A
magnified view is included




phenotypes are observed in genes such as sma-1 (b H-spectrin),
spc-1 (a -spectrin), hmr-1 (cadherin) and hmp-1 and hmp-2
(catenins), the products of which are required to tether actin
filaments to the membranes of the lateral epidermal cells
(Costa et al., 1998; McKeown et al., 1998; Norman and
Moerman, 2002). We found that spc-1 and sma-1 are
genetically epistatic with mel-11, suggesting that mel-11
hypercontraction requires the anchoring of actin cables by
these genes (Table 1). However, if LET-502 is involved in
anchoring these cables, then we would expect high levels of
LET-502 (a possible positive regulator of actin anchoring)
and low levels of MEL-11 (a possible negative regulator of
anchoring) at the membrane. However, we saw the exact
opposite staining pattern (Fig. 5). As reported by Norman and
Moerman (Norman and Moerman, 2002), we observed normal
actin filaments in let-502 and mlc-4 mutants, as well as in nmy-
1(sb113) and mel-11(it26) embryos (data not shown). Our
results thus suggest that LET-502 and MEL-11 are not required
to anchor actin filaments, but likely regulate the contraction of
filaments. However, LET-502 and MEL-11 are present at the
AJs of the pharynx and gut, and could be required for some
aspect of AJ formation or function in these organs.
MEL-11 requires NMY-1 for membrane localization
Drosophila Zipper/nonmuscle myosin requires Spaghetti
squash/rMLC for localization (Edwards and Kiehart, 1996;
Jordan and Karess, 1997; Wheatley et al., 1995). We found that
NMY-1 similarly failed to form filamentous-like structures in
mlc-4-null mutant embryos, with NMY-1 collapsing into large
foci (Fig. 8A).
As myosin is the target of MEL-11, we expected that MEL-
11 localization might change in nmy-1 and mlc-4 mutants.
However, mlc-4 embryos displayed wild-type patterns of MEL-
11 (Fig. 8B,C) and F-actin distribution (data not shown)
(Norman and Moerman, 2002). We also examined nmy-
1(sb113); nmy-2(RNAi) embryos, which lack all MHC and
arrest at a similar stage to mlc-4. MEL-11 no longer localized
to membranes (Fig. 8D-F). When MHC was partly eliminated
using nmy-1(sb113), membrane localization of MEL-11 was
frequently decreased and occasionally was absent. An extreme
case is shown in Fig. 8G-I, which may correspond to those rare
sb113 embryos where elongation failed. These results may
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Fig. 7. MEL-11 is dependent on LET-502 for its localization. Although
only low levels of cytoplasmic anti-MEL-11 staining was present in
the lateral epidermal cells of wild type (A), higher cytoplasmic levels
were present in let-502(ca201) (B), which arrests at the onset of
elongation. let-502(sb106) embryos undergo elongation, albeit
abnormally, and also show higher levels of cytoplasmic MEL-11 (C).
The let-502(sb106) embryos in D is at a later stage than that in C, and
again showed higher levels of cytoplasmic MEL-11 compared with
wild type (A). The embryo in D presents a more ventral aspect; the
posterior lateral epidermal cells indicated by the bracket were in the
focal plane and show increased cytoplasmic MEL-11. All images were
deconvolved. Scale bar: 10 m m.
Fig. 8. NMY-1 and MEL-11
localization in myosin-
depleted embryos. In mlc-4
embryos, NMY-1 collapsed
into large foci (A), but MEL-
11 was unaffected (B). A
merged image is shown in
(C, NMY-1 red, MEL-11
green). However, although
LET-502 appeared normal
(D), MEL-11 was clearly
disrupted in nmy-1(sb113);
nmy-1(RNAi) embryos (E,
merged image shown in F
with LET-502 red, MEL-11
green) where it remained
cytoplasmic in comparison to
its membrane location in
wild-type embryos of similar
stages (e.g. Fig. 5E). MEL-
11 membrane localization
was decreased compared
with the normal pattern of
LET-502 (G), or as shown in
this embryo (H), occasionally
absent when total NMY was
only partially depleted in nmy-1(sb113) (I, merged image, LET-502 red, MEL-11 green). Scale bar: 10 m m.
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indicate that the LET-502 interaction that directs MEL-11 to
the membrane likely requires MEL-11 binding to MHC. 
Discussion
NMY-1 is a nonmuscle MHC partner for MLC-4
during elongation
Elongation of the C. elegans embryo occurs due to actin-
mediated contractions within the lateral epidermal (seam) cells
(Priess and Hirsh, 1986). We previously identified a pathway that
regulates elongation that includes LET-502/ROK and MEL-
11/MYPT (Piekny et al., 2000; Piekny and Mains, 2002;
Wissmann et al., 1997; Wissmann et al., 1999). MEL-11
prevents contraction by dephosphorylating MLC-4/rMLC.
LET-502 in turn inhibits MEL-11, releasing the block to
elongation. We describe a new component of the pathway, NMY-
1/MHC, identified by mutations that suppress mel-11(–)
hypercontraction. Based on genetic and molecular analyses,
NMY-1 is an MHC partner for MLC-4/rMLC. Fig. 9 models
how NMY-1, LET-502 and MEL-11 regulate elongation. At
the onset of morphogenesis, actin and NMY-1 each form
filamentous-like structures that probably constitute the
contractile apparatus that drives elongation (Fig. 4). Similar to
MYPT during smooth muscle contraction (Shin et al., 2002),
MEL-11 moves from the cytoplasm to the membrane, away from
the contractile apparatus, when contraction begins (Figs 5 and
6). After elongation is complete, low levels of cytoplasmic MEL-
11 reappear. This MEL-11 membrane sequesterization depends
at least in part on let-502 activity, consistent with LET-502
triggering elongation by MEL-11 inhibition (Fig. 7). Membrane
localization was also disrupted when total NMY levels are
reduced or eliminated, suggesting that the MEL-11/LET-502
interaction occurs on myosin (Fig. 8). Thus, the defective
elongation seen in nmy-1 mutants may not only stem from
decreased amounts of MHC, but also from an inhibition of
myosin activity by the increased levels of cytoplasmic MEL-11.
In contrast to MEL-11 membrane sequesterization during
elongation, LET-502 is interspersed with the myosin filaments
(Fig. 6). In addition to triggering contraction by MYPT
inhibition, ROK can directly phosphorylate rMLC in some in
vitro systems (Amano et al., 1996). The localization of LET-
502 with the NMY-1 filaments is consistent with this possibility. 
Similar to what is seen in Drosophila (Edwards and Kiehart,
1996; Jordan and Karess, 1997; Wheatley et al., 1995), NMY-
1 fails to form filaments in mlc-4 mutants but instead forms
discrete foci, suggesting that MLC-4 is required for the proper
myosin organization. In higher eukaryotes, rMLC is not
required for MHC to assemble into contractile units, but rMLC
phosphorylation establishes contacts between myosin and actin
filaments (Trybus, 1996). Perhaps actin association is required
to assemble NMY-1 into the ordered arrays we observe in C.
elegans embryos. In the absence of mlc-4/rMLC, NMY-1
assembly is more random, forming the large foci rather than
parallel arrays.
In addition to a role for LET-502 and MEL-11 in regulating
the contraction of actin, an alternative model would suggest that
like their mammalian homologs in focal adhesion formation,
LET-502 and MEL-11 could regulate the attachment of actin
cables at the apical surfaces of lateral epidermal cells. The C.
elegans a and b H-spectrin genes, spc-1 and sma-1, respectively,
display elongation defects not unlike those seen in let-502 or
mlc-4 mutants (McKeown et al., 1998; Norman and Moerman,
2002), and we observed that spc-1 and sma-1 are epistatic to
mel-11 hypercontraction (Table 1). However, Norman and
Moerman (Norman and Moerman, 2002) showed that the actin
cables were not disrupted in let-502 and mlc-4 mutants, and we
found that this was also the case for mel-11 and nmy-1.
Moreover, the immunolocalization patterns for LET-502 and
MEL-11 are opposite to that predicted by the actin anchoring
model: LET-502, which would be predicted to tether actin to
the membrane, remains cytoplasmic, while MEL-11, which
would release the cables, is found at the membrane. Therefore,
these results support a role for the LET-502/MEL-11 pathway
in regulating the contraction of actin/myosin rather than
anchoring of actin filaments.
nmy-2 is partially redundant with nmy-1 during
elongation
Our analysis of nmy-1 suggests that it functions redundantly
with another gene during embryonic elongation. The nmy-1
null phenotype, a mis-shapen adult, is much less severe than
expected if it were the only MHC to regulate this process as
mlc-4, the only rMLC known to function during elongation,
displays arrest as unelongated L1 larva (Shelton et al., 1999).
We demonstrated that a second MHC gene, nmy-2, functions
redundantly with nmy-1. nmy-2(RNAi) disrupts AP polarity and
cytokinesis in the early embryo (Cuenca et al., 2003; Guo and
Kemphues, 1996), which prevented examining nmy-2 function
later in embryogenesis. However, we found that NMY-2 is
present in epidermal cells at the onset of elongation, where it
likely assembles into filamentous structures similar to NMY-1.
Furthermore, nmy-2(weak RNAi); nmy-1 double mutants
displayed elongation-defective phenotypes similar to mlc-4
that were not seen for either nmy-2(weak RNAi) or nmy-1 alone
(Table 3). Therefore, we have uncovered a role for nmy-2 in
elongation.
To summarize, we have isolated a new component of the let-
Fig. 9. A cartoon model demonstrating how actin, NMY-1, LET-502
and MEL-11 regulate elongation of lateral epidermal cells. Prior to
elongation, actin (red) is disorganized and NMY-1 (black), LET-502
(blue) and MEL-11 (green) are present throughout the cell. In the
early stages of elongation, actin filaments organize perpendicular to
the direction of the future cell shape changes. NMY-1 begins to
organize into filaments, where it could function as a motor to shorten
actin filaments. LET-502 remains at high levels within the cell where
it likely phosphorylates and thus sequesters MEL-11 to the
membrane. By the end of elongation, NMY-1 forms perpendicular
lines similar to actin. LET-502 remains associated with NMY-1 and
MEL-11 loses its strong membrane localization and partially returns
to the cytoplasm, where it could downregulate myosin activity.
5704
502/mel-11 pathway, nmy-1, which encodes a nonmuscle MHC
that functions with mlc-4/rMLC to regulate the contractile
process of embryonic elongation. nmy-1 functions redundantly
with a second nonmuscle MHC gene, nmy-2. Together the two
MHCs ensure the successful elongation of embryos into the
characteristic long, thin worm. 
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